COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis

In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options. Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets as...

Full description

Saved in:
Bibliographic Details
Published inEBioMedicine Vol. 82; p. 104185
Main Authors Sinha, Saptarshi, Castillo, Vanessa, Espinoza, Celia R., Tindle, Courtney, Fonseca, Ayden G., Dan, Jennifer M., Katkar, Gajanan D., Das, Soumita, Sahoo, Debashis, Ghosh, Pradipta
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.08.2022
Elsevier
Subjects
Online AccessGet full text
ISSN2352-3964
2352-3964
DOI10.1016/j.ebiom.2022.104185

Cover

Abstract In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options. Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR. COVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2. Like IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases. This work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780).
AbstractList In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options. Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR. COVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2. Like IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases. This work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780).
SummaryBackgroundIn the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post- COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options. MethodsUsing an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR. FindingsCOVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2. InterpretationLike IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases. FundingThis work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780).
In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options.BACKGROUNDIn the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options.Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR.METHODSUsing an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR.COVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2.FINDINGSCOVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2.Like IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases.INTERPRETATIONLike IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases.This work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780).FUNDINGThis work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780).
Background: In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options. Methods: Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR. Findings: COVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2. Interpretation: Like IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases. Funding: This work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780).
ArticleNumber 104185
Author Dan, Jennifer M.
Fonseca, Ayden G.
Espinoza, Celia R.
Ghosh, Pradipta
Castillo, Vanessa
Tindle, Courtney
Das, Soumita
Sinha, Saptarshi
Sahoo, Debashis
Katkar, Gajanan D.
Author_xml – sequence: 1
  givenname: Saptarshi
  surname: Sinha
  fullname: Sinha, Saptarshi
  organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA
– sequence: 2
  givenname: Vanessa
  surname: Castillo
  fullname: Castillo, Vanessa
  organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA
– sequence: 3
  givenname: Celia R.
  surname: Espinoza
  fullname: Espinoza, Celia R.
  organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA
– sequence: 4
  givenname: Courtney
  surname: Tindle
  fullname: Tindle, Courtney
  organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA
– sequence: 5
  givenname: Ayden G.
  surname: Fonseca
  fullname: Fonseca, Ayden G.
  organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA
– sequence: 6
  givenname: Jennifer M.
  surname: Dan
  fullname: Dan, Jennifer M.
  organization: Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA
– sequence: 7
  givenname: Gajanan D.
  surname: Katkar
  fullname: Katkar, Gajanan D.
  organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA
– sequence: 8
  givenname: Soumita
  surname: Das
  fullname: Das, Soumita
  organization: Department of Pathology, University of California San Diego, La Jolla, CA 92093, USA
– sequence: 9
  givenname: Debashis
  surname: Sahoo
  fullname: Sahoo, Debashis
  email: dsahoo@ucsd.edu
  organization: Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA
– sequence: 10
  givenname: Pradipta
  orcidid: 0000-0002-8917-3201
  surname: Ghosh
  fullname: Ghosh, Pradipta
  email: prghosh@ucsd.edu
  organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35870428$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1rGzEQXUpKk6b5BYWyx17sSqPdlURpILhfhkAOTXus0GpnbbnrlSNpXfzvq42TkASKL5KYee_NaOa9zo5612OWvaVkSgmtPqymWFu3ngIBSJGCivJFdgKshAmTVXH06H2cnYWwIoTQskhB8So7TicnBYiT7Pfs6tf884TKvBv6Rd7YgDpgHpbaY8gbb7fo84tryM0uuo2OS2vyFnUcxvRfG5f5vLH3ic3QrV2v_S5vbe1dsOFN9rLVXcCzu_s0-_n1y_Xs--Ty6tt8dnE5MRWDOBF1Y4jUElgB3FAOmoIGFIhlWUnKCNctQMGLoiyLumWNQKJFLanmuiBEsNNsvtdtnF6pjbfr1IVy2qrbgPMLpX20pkPVlK2UphSCy8SFQmpkEgQxXJdtbVjSOt9rbYZ6jY3BPnrdPRF9muntUi3cVkmQXABPAu_vBLy7GTBEtbbBYNfpHt0QFFSScS4lH6HvHtd6KHK_oARge4BJ8wwe2wcIJWp0glqpWyeo0Qlq74TEks9YxkYdrRsbtt0B7qc9F9O-tha9CsZib7CxHk1MA7UH-OfP-KazvTW6-4M7DCs3-D5ZQVEVQBH1Y_TpaFMAQlhVjV_--H-Bg-X_AcC091E
CitedBy_id crossref_primary_10_1186_s12951_023_01821_6
crossref_primary_10_3390_microorganisms11040895
crossref_primary_10_1513_AnnalsATS_202406_651ST
crossref_primary_10_26508_lsa_202302026
crossref_primary_10_1165_rcmb_2023_0426TR
crossref_primary_10_3389_fphar_2023_1143158
crossref_primary_10_1038_s41467_024_52810_8
crossref_primary_10_3390_ijms242216410
crossref_primary_10_1186_s12931_024_02738_w
crossref_primary_10_3390_cimb46050261
crossref_primary_10_1002_ptr_8070
crossref_primary_10_1016_j_pccm_2023_10_007
crossref_primary_10_1016_j_envint_2024_108415
crossref_primary_10_3389_fpubh_2023_1295457
crossref_primary_10_1111_apha_14059
crossref_primary_10_3390_biom14020236
crossref_primary_10_1152_ajpcell_00239_2023
crossref_primary_10_1007_s00134_022_06877_w
crossref_primary_10_3390_biology12091196
crossref_primary_10_1016_j_ebiom_2024_105136
crossref_primary_10_1186_s13287_023_03414_4
Cites_doi 10.1016/j.stem.2020.06.020
10.1016/j.ebiom.2021.103513
10.4049/jimmunol.1801648
10.1038/s41467-021-23328-0
10.1038/nature03712
10.1038/s41467-021-21085-8
10.1056/NEJMra1705751
10.1017/S1431927611011925
10.1056/NEJMoa2116044
10.1186/gb-2008-9-10-r157
10.1016/S2213-2600(17)30349-1
10.1183/13993003.00642-2015
10.3389/fimmu.2019.03150
10.1164/rccm.202006-2441LE
10.1165/rcmb.2019-0071OC
10.1172/JCI93556
10.1016/j.immuni.2020.12.003
10.1016/j.ebiom.2021.103390
10.3390/cells10030611
10.1093/nar/gkm284
10.3390/jcm9041178
10.1084/jem.20141732
10.1073/pnas.1504780112
10.2174/1871528113666140713164506
10.1056/NEJMoa2015432
10.1080/20018525.2020.1853658
10.3390/ijms22116151
10.1513/AnnalsATS.201303-069FR
10.18632/aging.202463
10.3389/fimmu.2020.587517
10.24018/ejmed.2021.3.1.670
10.1038/nm1578
10.1097/MCP.0000000000000301
10.21037/jtd-21-462
10.1056/NEJMe0903992
10.1164/rccm.202007-2638LE
10.1148/radiol.2021204482
10.1164/rccm.201902-0451OC
10.1016/S0140-6736(03)14630-2
10.1126/scitranslmed.abb5883
10.1038/srep07027
10.1371/journal.pone.0096801
10.1513/AnnalsATS.202008-1002OC
10.1016/j.ajpath.2013.03.014
10.1126/sciadv.abh2434
10.1093/nar/gkaa1074
10.1038/s41564-020-00835-2
10.1164/rccm.202007-2794OC
10.1186/1755-8794-4-70
10.1146/annurev-immunol-032713-120231
10.1093/infdis/jis340
10.1002/jum.15563
10.1016/j.ebiom.2021.103595
10.1172/JCI139519
10.1073/pnas.0913635107
10.1126/sciimmunol.abk1741
10.1038/nm.4192
10.1165/rcmb.2021-0205LE
10.1016/S2213-2600(21)00077-1
10.1038/s41556-020-0542-8
10.1172/JCI118321
10.1016/S2213-2600(20)30225-3
10.1172/JCI68782
10.3390/ijms22105131
10.1038/s41467-022-30357-w
10.1186/ar2284
10.1016/j.idcr.2020.e01041
10.1253/circj.CJ-12-1544
10.1186/cc9259
10.2741/pardo
10.1016/j.trsl.2019.12.002
10.1126/sciadv.aba1983
10.3390/ijms22126214
10.1371/journal.ppat.1004869
10.1371/journal.pone.0215565
10.1038/ncomms5451
10.1038/d41586-020-02598-6
10.1084/jem.180.4.1395
10.1164/rccm.202010-3918ED
10.1016/j.autrev.2020.102537
10.1016/j.trsl.2013.06.004
10.1126/scitranslmed.abe4282
10.4049/jimmunol.1900579
10.1128/JVI.01965-17
10.1126/science.abc7520
10.1183/13993003.02951-2021
10.1016/S2213-2600(21)00174-0
10.1111/acel.12161
10.1056/NEJMra052211
10.1513/AnnalsATS.202102-223ED
10.1155/2011/531302
10.1038/s12276-019-0371-7
10.1016/j.rmed.2018.06.012
10.1136/thoraxjnl-2021-217031
10.1101/gad.1836009
10.18632/aging.104097
10.1038/s41577-021-00536-9
10.1016/j.exger.2020.110836
10.1002/ctm2.224
10.1016/j.celrep.2016.11.001
10.1038/s41556-020-0561-5
10.1093/nar/gkx1132
10.7554/eLife.66417
10.1371/journal.pone.0224839
10.1164/rccm.201712-2410OC
10.3390/ijms21072269
10.1164/rccm.202004-1274OC
10.1165/rcmb.2013-0310OC
10.1073/pnas.1117988108
10.1097/CCM.0000000000005089
10.1126/scitranslmed.aax5866
10.1067/mai.2001.119556
10.1056/NEJMoa1211721
10.1038/s41586-021-03995-1
10.1038/s41467-020-17358-3
10.1097/SHK.0000000000000633
10.1038/s41598-017-01765-6
10.1038/s41591-020-0901-9
10.1016/S2213-2600(20)30222-8
10.1371/journal.pone.0118528
10.1091/mbc.E19-01-0013
10.3390/genes10070531
10.15252/embj.2020105912
10.1172/jci.insight.90558
10.1126/scitranslmed.abj7790
ContentType Journal Article
Copyright 2022 The Author(s)
The Author(s)
Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.
2022 The Author(s) 2022
Copyright_xml – notice: 2022 The Author(s)
– notice: The Author(s)
– notice: Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.
– notice: 2022 The Author(s) 2022
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1016/j.ebiom.2022.104185
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE - Academic


MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2352-3964
EndPage 104185
ExternalDocumentID oai_doaj_org_article_d5f99c58879a40249ae39280c7a5fbc3
PMC9297827
35870428
10_1016_j_ebiom_2022_104185
S2352396422003668
1_s2_0_S2352396422003668
Genre Journal Article
GrantInformation This work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780).
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R25 AI147376
– fundername: NIGMS NIH HHS
  grantid: R01 GM138385
– fundername: NIAID NIH HHS
  grantid: R01 AI155696
– fundername: NIAID NIH HHS
  grantid: U19 AI142742
– fundername: NCATS NIH HHS
  grantid: UG3 TR003355
GroupedDBID .1-
.FO
0R~
4.4
457
53G
5VS
AAEDT
AAEDW
AAIKJ
AALRI
AAMRU
AAXUO
AAYWO
ABMAC
ACGFS
ACVFH
ADBBV
ADCNI
ADEZE
ADRAZ
ADVLN
AEUPX
AEXQZ
AFPUW
AFRHN
AFTJW
AGHFR
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
APXCP
BCNDV
EBS
EJD
FDB
GROUPED_DOAJ
HYE
HZ~
IPNFZ
KQ8
M41
M48
O9-
OK1
RIG
ROL
RPM
SSZ
Z5R
0SF
6I.
AACTN
AAFTH
AFCTW
NCXOZ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c632t-8bdc09a923427c172a12a2e8ee55691307af224744554bf3d8e0a8b91a7a40083
IEDL.DBID M48
ISSN 2352-3964
IngestDate Wed Aug 27 01:23:23 EDT 2025
Thu Aug 21 18:18:05 EDT 2025
Fri Sep 05 10:11:24 EDT 2025
Mon Jul 21 05:59:39 EDT 2025
Tue Jul 01 00:39:03 EDT 2025
Thu Apr 24 23:01:19 EDT 2025
Tue Jul 25 20:57:56 EDT 2023
Tue Feb 25 20:10:31 EST 2025
Tue Aug 26 17:01:35 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Senescence
Immune response
ER-stress
Interleukin 15 (IL15)
Damage-associated transient progenitor (DATP)
Artificial intelligence/machine learning
Alveolar type II pneumocytes
Language English
License This is an open access article under the CC BY-NC-ND license.
Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c632t-8bdc09a923427c172a12a2e8ee55691307af224744554bf3d8e0a8b91a7a40083
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Co-Corresponding.
ORCID 0000-0002-8917-3201
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.1016/j.ebiom.2022.104185
PMID 35870428
PQID 2693779977
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_d5f99c58879a40249ae39280c7a5fbc3
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9297827
proquest_miscellaneous_2693779977
pubmed_primary_35870428
crossref_primary_10_1016_j_ebiom_2022_104185
crossref_citationtrail_10_1016_j_ebiom_2022_104185
elsevier_sciencedirect_doi_10_1016_j_ebiom_2022_104185
elsevier_clinicalkeyesjournals_1_s2_0_S2352396422003668
elsevier_clinicalkey_doi_10_1016_j_ebiom_2022_104185
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-08-01
PublicationDateYYYYMMDD 2022-08-01
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle EBioMedicine
PublicationTitleAlternate EBioMedicine
PublicationYear 2022
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Rieppo, Janssen, Rahunen, Lehenkari, Finnilä, Saarakkala (bib0034) 2019; 14
Garcia (bib0065) 2018; 128
Lee IY, Ho JM, Chen MS. CLUGO: a clustering algorithm for automated functional annotations based on gene ontology. In Fifth IEEE International Conference on Data Mining (ICDM'05) 2005 Nov 27 (pp. 4-pp). IEEE.
Borok, Horie, Flodby (bib0089) 2020; 201
Lederer, Martinez (bib0043) 2018; 378
Carson, Giri, Lindemann (bib0025) 1994; 180
Chamberlain, Crowley, Kobayashi, Eliceiri, Vanderby (bib0033) 2011; 17
Bonham, Strek, Patterson (bib0037) 2016; 22
Sheahan, Sims, Zhou (bib0075) 2020; 12
Jayk Bernal, Gomes da Silva, Musungaie (bib0077) 2022; 386
van der Meer, Orsel, Barkema (bib0052) 2010; 51
Kaarteenaho, Kinnula (bib0012) 2011; 2011
Verheyden, Sun (bib0096) 2020; 22
Xi, Zhigang, Ting (bib0110) 2020; 6
Ghosh, Katkar, Shimizu (bib0035) 2022; 13
Evren, Ringqvist, Tripathi (bib0061) 2021; 54
Sahoo, Dill, Tibshirani, Plevritis (bib0019) 2007; 35
Ammar, Sivakumar, Jarai, Thompson (bib0042) 2019; 14
Zaki, van Boheemen, Bestebroer, Osterhaus, Fouchier (bib0057) 2012; 367
Cox, Wolf, Plemper (bib0072) 2021; 6
Podolanczuk, Richeldi (bib0106) 2020; 202
McGroder, Zhang, Choudhury (bib0119) 2021; 76
Bharat, Querrey, Markov (bib0015) 2020; 12
Kølner-Augustson, Prior, Skivild, Aalestrup, Bendstrup (bib0049) 2020; 8
Parimon, Hohmann, Yao (bib0098) 2021; 22
Takada, Ohashi, Hayashi (bib0113) 2018; 141
Lee, Yu, Trimpert (bib0128) 2021; 599
Parimon, Yao, Stripp, Noble, Chen (bib0064) 2020; 21
Lopez-Sanchez, Dunkel, Roh (bib0029) 2014; 5
Wagstaffe, Pickering, Houghton (bib0023) 2019; 203
Patterson, Strek (bib0038) 2013; 10
D'Agnillo, Walters, Xiao (bib0130) 2021; 13
Varghese, Bukhari, Malhotra, De (bib0032) 2014; 9
Bonaventura, Vecchié, Dagna (bib0084) 2021; 21
Rock, Barkauskas, Cronce (bib0090) 2011; 108
Nosaka, Ishida, Kimura (bib0087) 2019; 10
Hoek, Samir, Howard (bib0024) 2015; 10
Wu, Byers, Jin (bib0060) 2015; 212
Herazo-Maya, Sun, Molyneaux (bib0027) 2017; 5
Kobayashi, Tata, Konkimalla (bib0069) 2020; 22
Sahoo, Katkar, Khandelwal (bib0018) 2021; 68
Cheon, Li, Son (bib0014) 2021; 6
Maruhashi, Higashi (bib0085) 2021; 22
Lamers, van der Vaart, Knoops (bib0081) 2021; 40
Sahoo, Seita, Bhattacharya (bib0132) 2010; 107
Yao, Guan, Carraro (bib0070) 2021; 203
Ackermann, Verleden, Kuehnel (bib0013) 2020; 383
Kuba, Imai, Penninger (bib0103) 2013; 77
Ahmad Alhiyari, Ata, Islam Alghizzawi, Bint, Salih Abdulhadi, Yousaf (bib0007) 2021; 23
Gallay, Uzunhan, Borie (bib0107) 2021; 203
Alder, Barkauskas, Limjunyawong (bib0115) 2015; 112
Marshall (bib0048) 2020; 585
Firdaus, Razak, Reza, Khan, Shameem (bib0108) 2020; 14
Zhai, Franco, Atmar (bib0058) 2015; 11
Schneider, Chevillotte, Rice (bib0117) 2014; 32
Bermejo-Martin, Martin-Loeches, Rello (bib0053) 2010; 14
Zhong, Zheng, Li (bib0055) 2003; 362
Liu, Liu (bib0097) 2020; 132
Mongelli, Barbi, Gottardi Zamperla (bib0120) 2021; 22
Rogers, Zhao, Huang (bib0031) 2020; 369
Gagiannis, Steinestel, Hackenbroch (bib0009) 2020; 11
Strunz, Simon, Ansari (bib0068) 2020; 11
Toots, Yoon, Hart, Natchus, Painter, Plemper (bib0073) 2020; 218
Atabati, Dehghani-Samani, Mortazavimoghaddam (bib0006) 2020; 56
Dadhwal, Sharma, Surani (bib0005) 2021; 13
Toots, Yoon, Cox (bib0074) 2019; 11
Spagnolo, Balestro, Aliberti (bib0001) 2020; 8
Szklarczyk, Gable, Nastou (bib0021) 2021; 49
Choi, Park, Tsagkogeorga (bib0067) 2020; 27
Reyfman, Walter, Joshi (bib0044) 2019; 199
Zhou, Mao, Zhou (bib0093) 2014; 13
Imai, Kuba, Rao (bib0036) 2005; 436
Chen, Chen, Liang (bib0125) 2020; 52
Yang, Gu, Zhao (bib0078) 2014; 4
Bloem, Mostard, Stoot (bib0050) 2020; 9
Inlay, Bhattacharya, Sahoo (bib0100) 2009; 23
McGonagle, Sharif, O'Regan, Bridgewood (bib0111) 2020; 19
Carson, Ross, Baiocchi (bib0026) 1995; 96
Xu, Liu, Liao (bib0046) 2020; 10
Bharat, Machuca, Querrey (bib0017) 2021; 9
Esposito, Menon, Ghosh (bib0104) 2020; 202
Borok, Horie, Flodby (bib0121) 2020; 201
Fabregat, Jupe, Matthews (bib0020) 2018; 46
Froidure, Mahieu, Hoton (bib0118) 2020; 12
Dabydeen, Desai, Sahoo (bib0133) 2019; 30
Abdelnabi, Foo, Kaptein (bib0071) 2021; 72
Bloem, Mostard, Stoot, Vercoulen, Peters, Spruit (bib0051) 2021; 13
Bauer, Tedrow, de Bernard (bib0040) 2015; 52
Momen, Khan, Saber (bib0109) 2021; 3
Drake, Docherty, Harrison (bib0105) 2020; 202
Aviv (bib0095) 2021; 70
Bakowski, Beutler, Wolff (bib0030) 2021; 12
Beigel, Farrar, Han (bib0056) 2005; 353
Zhang, Luo, Zhong (bib0063) 2019; 10
Sodhi, Nguyen, Yamaguchi (bib0101) 2019; 203
Adams, Schupp, Poli (bib0045) 2020; 6
Gangwar, Kumar Sharma, Panzade, Awasthi, Agrawal, Shankar (bib0041) 2017; 7
Vasarmidi, Tsitoura, Spandidos, Tzanakis, Antoniou (bib0079) 2020; 20
Myall, Mukherjee, Castanheira (bib0002) 2021; 18
Fink, Orlova-Fink, Schindler (bib0022) 2020
Sanchez-Vazquez, Guío-Carrión, Zapatero-Gaviria, Martínez, Blasco (bib0094) 2021; 13
Urakova, Kuznetsova, Crossman (bib0076) 2018; 92
Rana, Jiang, Liu (bib0126) 2020; 62
Frank, Peng, Zepp (bib0092) 2016; 17
Senchenkova, Komoto, Russell (bib0086) 2013; 183
Abdul-Careem, Mian (bib0116) 2012; 206
Tindle, Fuller, Fonseca (bib0028) 2021; 10
Lipskaia, Maisonnasse, Fouillade (bib0129) 2021; 66
Wuttge, Wildt, Geborek, Wollheim, Scheja, Akesson (bib0114) 2007; 9
Xu, Mizuno, Sridharan (bib0123) 2016; 1
Pardo, Selman (bib0066) 2002; 7
Sahoo, Dill, Gentles, Tibshirani, Plevritis (bib0131) 2008; 9
Alharthy, Abuhamdah, Balhamar (bib0008) 2020; 40
Katzen, Beers (bib0088) 2020; 130
Gaddam, Chambers, Bhatia (bib0099) 2014; 13
Ju, Jiang, Jaworski (bib0134) 2007; 13
Muro, Taha, Tsicopoulos (bib0112) 2001; 108
Croci, Vaira, Trabattoni (bib0016) 2021; 10
Liang, Zhang, Xie (bib0122) 2016; 22
Barkauskas, Cronce, Rackley (bib0091) 2013; 123
van Gassel, Bels, Remij (bib0011) 2021; 49
Meltzer, Barry, D'Amico (bib0039) 2011; 4
Jia (bib0102) 2016; 46
Baden, Drazen, Kritek, Curfman, Morrissey, Campion (bib0054) 2009; 360
Barrett, Cornwell, Myndzar (bib0083) 2021; 7
Liao, Liu, Yuan (bib0059) 2020; 26
Leahy, McManus, Doherty (bib0062) 2016; 47
Pang, Xu, Aondio (bib0080) 2021; 12
Wells, Devaraj, Desai (bib0003) 2021; 299
Evangelou, Veroutis, Paschalaki (bib0127) 2022
Chilosi, Carloni, Rossi, Poletti (bib0124) 2013; 162
Aronson, Podolanczuk (bib0004) 2021; 18
George, Wells, Jenkins (bib0010) 2020; 8
Wu, Liu, Zhou (bib0047) 2021; 9
Bloem (10.1016/j.ebiom.2022.104185_bib0050) 2020; 9
Bakowski (10.1016/j.ebiom.2022.104185_bib0030) 2021; 12
Wells (10.1016/j.ebiom.2022.104185_bib0003) 2021; 299
Yao (10.1016/j.ebiom.2022.104185_bib0070) 2021; 203
Takada (10.1016/j.ebiom.2022.104185_bib0113) 2018; 141
Maruhashi (10.1016/j.ebiom.2022.104185_bib0085) 2021; 22
Liu (10.1016/j.ebiom.2022.104185_bib0097) 2020; 132
Lee (10.1016/j.ebiom.2022.104185_bib0128) 2021; 599
Dadhwal (10.1016/j.ebiom.2022.104185_bib0005) 2021; 13
Evangelou (10.1016/j.ebiom.2022.104185_bib0127) 2022
George (10.1016/j.ebiom.2022.104185_bib0010) 2020; 8
Sahoo (10.1016/j.ebiom.2022.104185_bib0018) 2021; 68
Gallay (10.1016/j.ebiom.2022.104185_bib0107) 2021; 203
Wu (10.1016/j.ebiom.2022.104185_bib0060) 2015; 212
Mongelli (10.1016/j.ebiom.2022.104185_bib0120) 2021; 22
Chilosi (10.1016/j.ebiom.2022.104185_bib0124) 2013; 162
Carson (10.1016/j.ebiom.2022.104185_bib0026) 1995; 96
Rogers (10.1016/j.ebiom.2022.104185_bib0031) 2020; 369
Garcia (10.1016/j.ebiom.2022.104185_bib0065) 2018; 128
Podolanczuk (10.1016/j.ebiom.2022.104185_bib0106) 2020; 202
Alder (10.1016/j.ebiom.2022.104185_bib0115) 2015; 112
Rana (10.1016/j.ebiom.2022.104185_bib0126) 2020; 62
Rieppo (10.1016/j.ebiom.2022.104185_bib0034) 2019; 14
Inlay (10.1016/j.ebiom.2022.104185_bib0100) 2009; 23
Ammar (10.1016/j.ebiom.2022.104185_bib0042) 2019; 14
Bharat (10.1016/j.ebiom.2022.104185_bib0017) 2021; 9
Varghese (10.1016/j.ebiom.2022.104185_bib0032) 2014; 9
Gaddam (10.1016/j.ebiom.2022.104185_bib0099) 2014; 13
Lederer (10.1016/j.ebiom.2022.104185_bib0043) 2018; 378
Kaarteenaho (10.1016/j.ebiom.2022.104185_bib0012) 2011; 2011
Xu (10.1016/j.ebiom.2022.104185_bib0046) 2020; 10
Zhang (10.1016/j.ebiom.2022.104185_bib0063) 2019; 10
Bharat (10.1016/j.ebiom.2022.104185_bib0015) 2020; 12
Bonham (10.1016/j.ebiom.2022.104185_bib0037) 2016; 22
Zhai (10.1016/j.ebiom.2022.104185_bib0058) 2015; 11
Chamberlain (10.1016/j.ebiom.2022.104185_bib0033) 2011; 17
Zhou (10.1016/j.ebiom.2022.104185_bib0093) 2014; 13
Chen (10.1016/j.ebiom.2022.104185_bib0125) 2020; 52
Hoek (10.1016/j.ebiom.2022.104185_bib0024) 2015; 10
Toots (10.1016/j.ebiom.2022.104185_bib0073) 2020; 218
Aronson (10.1016/j.ebiom.2022.104185_bib0004) 2021; 18
Ackermann (10.1016/j.ebiom.2022.104185_bib0013) 2020; 383
Firdaus (10.1016/j.ebiom.2022.104185_bib0108) 2020; 14
Parimon (10.1016/j.ebiom.2022.104185_bib0064) 2020; 21
Dabydeen (10.1016/j.ebiom.2022.104185_bib0133) 2019; 30
Bloem (10.1016/j.ebiom.2022.104185_bib0051) 2021; 13
Muro (10.1016/j.ebiom.2022.104185_bib0112) 2001; 108
Momen (10.1016/j.ebiom.2022.104185_bib0109) 2021; 3
Senchenkova (10.1016/j.ebiom.2022.104185_bib0086) 2013; 183
Borok (10.1016/j.ebiom.2022.104185_bib0121) 2020; 201
Aviv (10.1016/j.ebiom.2022.104185_bib0095) 2021; 70
Parimon (10.1016/j.ebiom.2022.104185_bib0098) 2021; 22
Yang (10.1016/j.ebiom.2022.104185_bib0078) 2014; 4
Abdul-Careem (10.1016/j.ebiom.2022.104185_bib0116) 2012; 206
Adams (10.1016/j.ebiom.2022.104185_bib0045) 2020; 6
Zhong (10.1016/j.ebiom.2022.104185_bib0055) 2003; 362
Choi (10.1016/j.ebiom.2022.104185_bib0067) 2020; 27
Toots (10.1016/j.ebiom.2022.104185_bib0074) 2019; 11
Croci (10.1016/j.ebiom.2022.104185_bib0016) 2021; 10
Lipskaia (10.1016/j.ebiom.2022.104185_bib0129) 2021; 66
Borok (10.1016/j.ebiom.2022.104185_bib0089) 2020; 201
Liang (10.1016/j.ebiom.2022.104185_bib0122) 2016; 22
Wuttge (10.1016/j.ebiom.2022.104185_bib0114) 2007; 9
Leahy (10.1016/j.ebiom.2022.104185_bib0062) 2016; 47
Ghosh (10.1016/j.ebiom.2022.104185_bib0035) 2022; 13
Sheahan (10.1016/j.ebiom.2022.104185_bib0075) 2020; 12
Cox (10.1016/j.ebiom.2022.104185_bib0072) 2021; 6
Evren (10.1016/j.ebiom.2022.104185_bib0061) 2021; 54
Myall (10.1016/j.ebiom.2022.104185_bib0002) 2021; 18
Baden (10.1016/j.ebiom.2022.104185_bib0054) 2009; 360
Beigel (10.1016/j.ebiom.2022.104185_bib0056) 2005; 353
Sahoo (10.1016/j.ebiom.2022.104185_bib0131) 2008; 9
Zaki (10.1016/j.ebiom.2022.104185_bib0057) 2012; 367
McGonagle (10.1016/j.ebiom.2022.104185_bib0111) 2020; 19
Ahmad Alhiyari (10.1016/j.ebiom.2022.104185_bib0007) 2021; 23
Kølner-Augustson (10.1016/j.ebiom.2022.104185_bib0049) 2020; 8
Kobayashi (10.1016/j.ebiom.2022.104185_bib0069) 2020; 22
Liao (10.1016/j.ebiom.2022.104185_bib0059) 2020; 26
Katzen (10.1016/j.ebiom.2022.104185_bib0088) 2020; 130
Rock (10.1016/j.ebiom.2022.104185_bib0090) 2011; 108
Urakova (10.1016/j.ebiom.2022.104185_bib0076) 2018; 92
Jayk Bernal (10.1016/j.ebiom.2022.104185_bib0077) 2022; 386
Alharthy (10.1016/j.ebiom.2022.104185_bib0008) 2020; 40
Nosaka (10.1016/j.ebiom.2022.104185_bib0087) 2019; 10
Pardo (10.1016/j.ebiom.2022.104185_bib0066) 2002; 7
Meltzer (10.1016/j.ebiom.2022.104185_bib0039) 2011; 4
Vasarmidi (10.1016/j.ebiom.2022.104185_bib0079) 2020; 20
Patterson (10.1016/j.ebiom.2022.104185_bib0038) 2013; 10
Sahoo (10.1016/j.ebiom.2022.104185_bib0132) 2010; 107
Imai (10.1016/j.ebiom.2022.104185_bib0036) 2005; 436
Drake (10.1016/j.ebiom.2022.104185_bib0105) 2020; 202
Bauer (10.1016/j.ebiom.2022.104185_bib0040) 2015; 52
Fabregat (10.1016/j.ebiom.2022.104185_bib0020) 2018; 46
Kuba (10.1016/j.ebiom.2022.104185_bib0103) 2013; 77
Atabati (10.1016/j.ebiom.2022.104185_bib0006) 2020; 56
Fink (10.1016/j.ebiom.2022.104185_bib0022) 2020
Xu (10.1016/j.ebiom.2022.104185_bib0123) 2016; 1
Herazo-Maya (10.1016/j.ebiom.2022.104185_bib0027) 2017; 5
Lamers (10.1016/j.ebiom.2022.104185_bib0081) 2021; 40
Gagiannis (10.1016/j.ebiom.2022.104185_bib0009) 2020; 11
Carson (10.1016/j.ebiom.2022.104185_bib0025) 1994; 180
Bonaventura (10.1016/j.ebiom.2022.104185_bib0084) 2021; 21
Wu (10.1016/j.ebiom.2022.104185_bib0047) 2021; 9
Verheyden (10.1016/j.ebiom.2022.104185_bib0096) 2020; 22
D'Agnillo (10.1016/j.ebiom.2022.104185_bib0130) 2021; 13
Jia (10.1016/j.ebiom.2022.104185_bib0102) 2016; 46
Barkauskas (10.1016/j.ebiom.2022.104185_bib0091) 2013; 123
Tindle (10.1016/j.ebiom.2022.104185_bib0028) 2021; 10
van der Meer (10.1016/j.ebiom.2022.104185_bib0052) 2010; 51
Strunz (10.1016/j.ebiom.2022.104185_bib0068) 2020; 11
Sahoo (10.1016/j.ebiom.2022.104185_bib0019) 2007; 35
Reyfman (10.1016/j.ebiom.2022.104185_bib0044) 2019; 199
Lopez-Sanchez (10.1016/j.ebiom.2022.104185_bib0029) 2014; 5
Bermejo-Martin (10.1016/j.ebiom.2022.104185_bib0053) 2010; 14
Sodhi (10.1016/j.ebiom.2022.104185_bib0101) 2019; 203
Marshall (10.1016/j.ebiom.2022.104185_bib0048) 2020; 585
Froidure (10.1016/j.ebiom.2022.104185_bib0118) 2020; 12
Esposito (10.1016/j.ebiom.2022.104185_bib0104) 2020; 202
Abdelnabi (10.1016/j.ebiom.2022.104185_bib0071) 2021; 72
Pang (10.1016/j.ebiom.2022.104185_bib0080) 2021; 12
Gangwar (10.1016/j.ebiom.2022.104185_bib0041) 2017; 7
Frank (10.1016/j.ebiom.2022.104185_bib0092) 2016; 17
Wagstaffe (10.1016/j.ebiom.2022.104185_bib0023) 2019; 203
10.1016/j.ebiom.2022.104185_bib0082
McGroder (10.1016/j.ebiom.2022.104185_bib0119) 2021; 76
Spagnolo (10.1016/j.ebiom.2022.104185_bib0001) 2020; 8
Barrett (10.1016/j.ebiom.2022.104185_bib0083) 2021; 7
Ju (10.1016/j.ebiom.2022.104185_bib0134) 2007; 13
Szklarczyk (10.1016/j.ebiom.2022.104185_bib0021) 2021; 49
van Gassel (10.1016/j.ebiom.2022.104185_bib0011) 2021; 49
Cheon (10.1016/j.ebiom.2022.104185_bib0014) 2021; 6
Schneider (10.1016/j.ebiom.2022.104185_bib0117) 2014; 32
Xi (10.1016/j.ebiom.2022.104185_bib0110) 2020; 6
Sanchez-Vazquez (10.1016/j.ebiom.2022.104185_bib0094) 2021; 13
34873597 - bioRxiv. 2022 Jul 18:2021.11.28.470269. doi: 10.1101/2021.11.28.470269
References_xml – volume: 10
  start-page: 611
  year: 2021
  ident: bib0016
  article-title: Emergency lung transplantation after COVID-19: immunopathological insights on two affected patients
  publication-title: Cells
– volume: 203
  start-page: 707
  year: 2021
  end-page: 717
  ident: bib0070
  article-title: Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis
  publication-title: Am J Respir Crit Care Med
– volume: 70
  year: 2021
  ident: bib0095
  article-title: Short telomeres and severe COVID-19: the connection conundrum
  publication-title: EBioMedicine
– volume: 22
  start-page: 934
  year: 2020
  end-page: 946
  ident: bib0069
  article-title: Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis
  publication-title: Nat Cell Biol
– volume: 112
  start-page: 5099
  year: 2015
  end-page: 5104
  ident: bib0115
  article-title: Telomere dysfunction causes alveolar stem cell failure
  publication-title: Proc Natl Acad Sci USA
– volume: 10
  start-page: e224
  year: 2020
  ident: bib0046
  article-title: Persistent viral activity, cytokine storm, and lung fibrosis in a case of severe COVID-19
  publication-title: Clin Transl Med
– volume: 10
  start-page: 531
  year: 2019
  ident: bib0063
  article-title: SCINA: a semi-supervised subtyping algorithm of single cells and bulk samples
  publication-title: Genes (Basel)
– volume: 11
  start-page: eaax5866
  year: 2019
  ident: bib0074
  article-title: Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
  publication-title: Sci Transl Med
– volume: 108
  start-page: 970
  year: 2001
  end-page: 975
  ident: bib0112
  article-title: Expression of IL-15 in inflammatory pulmonary diseases
  publication-title: J Allergy Clin Immunol
– volume: 22
  start-page: 6151
  year: 2021
  ident: bib0120
  article-title: Evidence for biological age acceleration and telomere shortening in COVID-19 survivors
  publication-title: Int J Mol Sci
– volume: 52
  start-page: 130
  year: 2020
  end-page: 151
  ident: bib0125
  article-title: TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency
  publication-title: Exp Mol Med
– volume: 9
  start-page: 1178
  year: 2020
  ident: bib0050
  article-title: Severe fatigue is highly prevalent in patients with IPF or sarcoidosis
  publication-title: J Clin Med
– volume: 19
  year: 2020
  ident: bib0111
  article-title: The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease
  publication-title: Autoimmun Rev
– volume: 9
  start-page: 487
  year: 2021
  end-page: 497
  ident: bib0017
  article-title: Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries
  publication-title: Lancet Respir Med
– volume: 12
  start-page: eabb5883
  year: 2020
  ident: bib0075
  article-title: An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
  publication-title: Sci Transl Med
– volume: 10
  year: 2015
  ident: bib0024
  article-title: A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination
  publication-title: PLoS One
– volume: 68
  year: 2021
  ident: bib0018
  article-title: AI-guided discovery of the invariant host response to viral pandemics
  publication-title: EBioMedicine
– volume: 5
  start-page: 857
  year: 2017
  end-page: 868
  ident: bib0027
  article-title: Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
  publication-title: Lancet Respir Med
– year: 2022
  ident: bib0127
  article-title: Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis
  publication-title: Eur Respir J
– volume: 54
  start-page: 259
  year: 2021
  end-page: 275
  ident: bib0061
  article-title: Distinct developmental pathways from blood monocytes generate human lung macrophage diversity
  publication-title: Immunity
– volume: 66
  start-page: 107
  year: 2021
  end-page: 111
  ident: bib0129
  article-title: Evidence that SARS-CoV-2 induces lung-cell senescence: potential impact on COVID-19 lung disease
  publication-title: Am J Respir Cell Mol Biol
– volume: 12
  start-page: 19911
  year: 2020
  end-page: 19922
  ident: bib0118
  article-title: Short telomeres increase the risk of severe COVID-19
  publication-title: Aging (Albany NY)
– volume: 11
  start-page: 3559
  year: 2020
  ident: bib0068
  article-title: Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis
  publication-title: Nat Commun
– volume: 40
  year: 2021
  ident: bib0081
  article-title: An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells
  publication-title: EMBO J
– volume: 4
  start-page: 70
  year: 2011
  ident: bib0039
  article-title: Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle
  publication-title: BMC Med Genomics
– volume: 4
  start-page: 7027
  year: 2014
  ident: bib0078
  article-title: Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
  publication-title: Sci Rep
– volume: 13
  start-page: 742
  year: 2007
  end-page: 747
  ident: bib0134
  article-title: Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment
  publication-title: Nat Med
– volume: 56
  start-page: 1
  year: 2020
  end-page: 9
  ident: bib0006
  article-title: Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: a narrative review
  publication-title: Can J Respir Ther
– volume: 40
  start-page: 1823
  year: 2020
  end-page: 1838
  ident: bib0008
  article-title: Residual lung injury in patients recovering from COVID-19 critical illness: a prospective longitudinal point-of-care lung ultrasound study
  publication-title: J Ultrasound Med
– reference: Lee IY, Ho JM, Chen MS. CLUGO: a clustering algorithm for automated functional annotations based on gene ontology. In Fifth IEEE International Conference on Data Mining (ICDM'05) 2005 Nov 27 (pp. 4-pp). IEEE.
– volume: 17
  start-page: 779
  year: 2011
  end-page: 787
  ident: bib0033
  article-title: Quantification of collagen organization and extracellular matrix factors within the healing ligament
  publication-title: Microsc Microanal
– volume: 199
  start-page: 1517
  year: 2019
  end-page: 1536
  ident: bib0044
  article-title: Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis
  publication-title: Am J Respir Crit Care Med
– volume: 3
  start-page: 24
  year: 2021
  end-page: 26
  ident: bib0109
  article-title: Usefulness of pirfenidone in covid lung: a case series
  publication-title: Eur J Med Health Sci
– volume: 13
  start-page: 2687
  year: 2022
  ident: bib0035
  article-title: An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease
  publication-title: Nat Commun
– volume: 132
  year: 2020
  ident: bib0097
  article-title: Cell senescence and fibrotic lung diseases
  publication-title: Exp Gerontol
– volume: 202
  start-page: 1656
  year: 2020
  end-page: 1665
  ident: bib0105
  article-title: Outcome of Hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study
  publication-title: Am J Respir Crit Care Med
– volume: 72
  year: 2021
  ident: bib0071
  article-title: The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
  publication-title: EBioMedicine
– volume: 23
  start-page: e01041
  year: 2021
  ident: bib0007
  article-title: Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection
  publication-title: IDCases
– volume: 27
  start-page: 366
  year: 2020
  end-page: 382
  ident: bib0067
  article-title: Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration
  publication-title: Cell Stem Cell
– volume: 9
  start-page: e96801
  year: 2014
  ident: bib0032
  article-title: IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples
  publication-title: PLoS One
– volume: 49
  start-page: D605
  year: 2021
  end-page: D612
  ident: bib0021
  article-title: The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets
  publication-title: Nucleic Acids Res
– volume: 6
  year: 2021
  ident: bib0014
  article-title: Immune signatures underlying post-acute COVID-19 lung sequelae
  publication-title: Sci Immunol
– volume: 18
  start-page: 773
  year: 2021
  end-page: 774
  ident: bib0004
  article-title: Lungs after COVID-19: evolving knowledge of post-COVID-19 interstitial lung disease
  publication-title: Ann Am Thorac Soc
– volume: 22
  start-page: 6214
  year: 2021
  ident: bib0098
  article-title: Cellular senescence: pathogenic mechanisms in lung fibrosis
  publication-title: Int J Mol Sci
– volume: 10
  start-page: 3150
  year: 2019
  ident: bib0087
  article-title: Crucial involvement of IL-6 in thrombus resolution in mice via macrophage recruitment and the induction of proteolytic enzymes
  publication-title: Front Immunol
– volume: 30
  start-page: 1770
  year: 2019
  end-page: 1779
  ident: bib0133
  article-title: Unbiased Boolean analysis of public gene expression data for cell cycle gene identification
  publication-title: Mol Biol Cell
– volume: 180
  start-page: 1395
  year: 1994
  end-page: 1403
  ident: bib0025
  article-title: Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
  publication-title: J Exp Med
– volume: 49
  year: 2021
  ident: bib0011
  article-title: Functional outcomes and their association with physical performance in mechanically ventilated coronavirus disease 2019 survivors at 3 months following hospital discharge: a cohort study
  publication-title: Crit Care Med
– volume: 353
  start-page: 1374
  year: 2005
  end-page: 1385
  ident: bib0056
  article-title: Avian influenza A (H5N1) infection in humans
  publication-title: N Engl J Med
– volume: 585
  start-page: 339
  year: 2020
  end-page: 341
  ident: bib0048
  article-title: The lasting misery of coronavirus long-haulers
  publication-title: Nature
– volume: 7
  start-page: 1554
  year: 2017
  ident: bib0041
  article-title: Detecting the molecular system signatures of idiopathic pulmonary fibrosis through integrated genomic analysis
  publication-title: Sci Rep
– volume: 202
  start-page: 1614
  year: 2020
  end-page: 1616
  ident: bib0106
  article-title: COVID-19 and interstitial lung disease: keep them separate
  publication-title: Am J Respir Crit Care Med
– volume: 599
  start-page: 283
  year: 2021
  end-page: 289
  ident: bib0128
  article-title: Virus-induced senescence is a driver and therapeutic target in COVID-19
  publication-title: Nature
– volume: 14
  start-page: 14
  year: 2020
  end-page: 16
  ident: bib0108
  article-title: Clinical improvement with pirfenidone in two patients of COVID 19
  publication-title: J Clin Diagnostic Res
– volume: 35
  start-page: 3705
  year: 2007
  end-page: 3712
  ident: bib0019
  article-title: Extracting binary signals from microarray time-course data
  publication-title: Nucleic Acids Res
– volume: 203
  start-page: 1609
  year: 2019
  end-page: 1618
  ident: bib0023
  article-title: Influenza vaccination primes human myeloid cell cytokine secretion and NK cell function
  publication-title: J Immunol
– volume: 9
  start-page: 747
  year: 2021
  end-page: 754
  ident: bib0047
  article-title: 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
  publication-title: Lancet Respir Med
– volume: 52
  start-page: 217
  year: 2015
  end-page: 231
  ident: bib0040
  article-title: A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis
  publication-title: Am J Respir Cell Mol Biol
– volume: 13
  start-page: eabj7790
  year: 2021
  ident: bib0130
  article-title: Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
  publication-title: Sci Transl Med
– volume: 202
  start-page: 1710
  year: 2020
  end-page: 1713
  ident: bib0104
  article-title: Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control Study
  publication-title: Am J Respir Crit Care Med
– volume: 212
  start-page: 681
  year: 2015
  end-page: 697
  ident: bib0060
  article-title: TREM-2 promotes macrophage survival and lung disease after respiratory viral infection
  publication-title: J Exp Med
– volume: 9
  start-page: R85
  year: 2007
  ident: bib0114
  article-title: Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease
  publication-title: Arthritis Res Ther
– volume: 22
  start-page: 484
  year: 2016
  end-page: 491
  ident: bib0037
  article-title: From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis
  publication-title: Curr Opin Pulm Med
– volume: 8
  start-page: 807
  year: 2020
  end-page: 815
  ident: bib0010
  article-title: Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
  publication-title: Lancet Respir Med
– volume: 11
  year: 2015
  ident: bib0058
  article-title: Host transcriptional response to influenza and other acute respiratory viral infections–a prospective cohort study
  publication-title: PLoS Pathog
– volume: 12
  year: 2020
  ident: bib0015
  article-title: Lung transplantation for patients with severe COVID-19
  publication-title: Sci Transl Med
– volume: 183
  start-page: 173
  year: 2013
  end-page: 181
  ident: bib0086
  article-title: Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis
  publication-title: Am J Pathol
– volume: 108
  start-page: E1475
  year: 2011
  end-page: E1483
  ident: bib0090
  article-title: Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition
  publication-title: Proc Natl Acad Sci USA
– volume: 46
  start-page: D649
  year: 2018
  end-page: DD55
  ident: bib0020
  article-title: The reactome pathway knowledgebase
  publication-title: Nucleic Acids Res
– volume: 13
  start-page: e12501
  year: 2021
  ident: bib0005
  article-title: Restrictive lung disease in patients with subclinical coronavirus infection: are we bracing ourselves for devastating sequelae?
  publication-title: Cureus
– volume: 96
  start-page: 2578
  year: 1995
  end-page: 2582
  ident: bib0026
  article-title: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro
  publication-title: J Clin Invest
– volume: 76
  start-page: 1242
  year: 2021
  end-page: 1245
  ident: bib0119
  article-title: Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length
  publication-title: Thorax
– volume: 20
  start-page: 2557
  year: 2020
  end-page: 2560
  ident: bib0079
  article-title: Pulmonary fibrosis in the aftermath of the COVID-19 era (Review)
  publication-title: Exp Ther Med
– volume: 13
  start-page: 224
  year: 2014
  end-page: 234
  ident: bib0099
  article-title: ACE and ACE2 in inflammation: a tale of two enzymes
  publication-title: Inflamm Allergy Drug Targets
– volume: 17
  start-page: 2312
  year: 2016
  end-page: 2325
  ident: bib0092
  article-title: Emergence of a wave of wnt signaling that regulates lung alveologenesis by controlling epithelial self-renewal and differentiation
  publication-title: Cell Rep
– volume: 51
  start-page: 56
  year: 2010
  end-page: 62
  ident: bib0052
  article-title: The new influenza A H1N1 virus: balancing on the interface of humans and animals
  publication-title: Can Vet J
– volume: 13
  start-page: 197
  year: 2014
  end-page: 200
  ident: bib0093
  article-title: Endoplasmic reticulum stress activates telomerase
  publication-title: Aging Cell
– volume: 12
  start-page: 3309
  year: 2021
  ident: bib0030
  article-title: Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
  publication-title: Nat Commun
– volume: 378
  start-page: 1811
  year: 2018
  end-page: 1823
  ident: bib0043
  article-title: Idiopathic pulmonary fibrosis
  publication-title: N Engl J Med
– volume: 22
  start-page: 1025
  year: 2020
  end-page: 1026
  ident: bib0096
  article-title: A transitional stem cell state in the lung
  publication-title: Nat Cell Biol
– volume: 23
  start-page: 2376
  year: 2009
  end-page: 2381
  ident: bib0100
  article-title: Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development
  publication-title: Genes Dev
– volume: 32
  start-page: 513
  year: 2014
  end-page: 545
  ident: bib0117
  article-title: Interferon-stimulated genes: a complex web of host defenses
  publication-title: Annu Rev Immunol
– volume: 13
  start-page: 1
  year: 2021
  end-page: 15
  ident: bib0094
  article-title: Shorter telomere lengths in patients with severe COVID-19 disease
  publication-title: Aging (Albany NY)
– volume: 1
  start-page: e90558
  year: 2016
  ident: bib0123
  article-title: Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis
  publication-title: JCI Insight
– volume: 10
  start-page: e66417
  year: 2021
  ident: bib0028
  article-title: Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19
  publication-title: Elife
– volume: 18
  start-page: 799
  year: 2021
  end-page: 806
  ident: bib0002
  article-title: Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment
  publication-title: Ann Am Thorac Soc
– volume: 206
  start-page: 167
  year: 2012
  end-page: 177
  ident: bib0116
  article-title: Critical role of natural killer cells in lung immunopathology during influenza infection in mice
  publication-title: J Infect Dis
– volume: 218
  start-page: 16
  year: 2020
  end-page: 28
  ident: bib0073
  article-title: Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model
  publication-title: Transl Res
– volume: 6
  start-page: eaba1983
  year: 2020
  ident: bib0045
  article-title: Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
  publication-title: Sci Adv
– volume: 6
  start-page: 051
  year: 2020
  end-page: 053
  ident: bib0110
  article-title: Post-inflammatory pulmonary fibrosis in a discharged COVID-19 patient: Effectively treated with Pirfenidone
  publication-title: Archives of Pulmonology and Respiratory Care
– volume: 10
  start-page: 362
  year: 2013
  end-page: 370
  ident: bib0038
  article-title: Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes
  publication-title: Ann Am Thorac Soc
– volume: 203
  start-page: 3000
  year: 2019
  end-page: 3012
  ident: bib0101
  article-title: A dynamic variation of pulmonary ACE2 is required to modulate neutrophilic inflammation in response to
  publication-title: J Immunol
– volume: 369
  start-page: 956
  year: 2020
  end-page: 963
  ident: bib0031
  article-title: Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
  publication-title: Science
– volume: 6
  start-page: 11
  year: 2021
  end-page: 18
  ident: bib0072
  article-title: Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
  publication-title: Nat Microbiol
– volume: 22
  start-page: 5131
  year: 2021
  ident: bib0085
  article-title: Pathophysiological association of endothelial dysfunction with fatal outcome in COVID-19
  publication-title: Int J Mol Sci
– volume: 201
  start-page: 198
  year: 2020
  end-page: 211
  ident: bib0121
  article-title: Grp78 loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis
  publication-title: Am J Respir Crit Care Med
– volume: 360
  start-page: 2666
  year: 2009
  end-page: 2667
  ident: bib0054
  article-title: H1N1 influenza A disease–information for health professionals
  publication-title: N Engl J Med
– volume: 201
  start-page: 198
  year: 2020
  end-page: 211
  ident: bib0089
  article-title: Loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis
  publication-title: Am J Respir Crit Care Med
– volume: 62
  start-page: 319
  year: 2020
  end-page: 330
  ident: bib0126
  article-title: PAI-1 regulation of TGF-β1-induced alveolar type II cell senescence, SASP secretion, and SASP-mediated activation of alveolar macrophages
  publication-title: Am J Respir Cell Mol Biol
– volume: 5
  start-page: 4451
  year: 2014
  ident: bib0029
  article-title: GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis
  publication-title: Nat Commun
– volume: 21
  start-page: 319
  year: 2021
  end-page: 329
  ident: bib0084
  article-title: Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
  publication-title: Nat Rev Immunol
– volume: 8
  start-page: 750
  year: 2020
  end-page: 752
  ident: bib0001
  article-title: Pulmonary fibrosis secondary to COVID-19: a call to arms?
  publication-title: Lancet Respir Med
– volume: 8
  year: 2020
  ident: bib0049
  article-title: Fatigue in idiopathic pulmonary fibrosis measured by the fatigue assessment scale during antifibrotic treatment
  publication-title: Eur Clin Respir J
– volume: 107
  start-page: 5732
  year: 2010
  end-page: 5737
  ident: bib0132
  article-title: MiDReG: a method of mining developmentally regulated genes using Boolean implications
  publication-title: Proc Natl Acad Sci USA
– volume: 436
  start-page: 112
  year: 2005
  end-page: 116
  ident: bib0036
  article-title: Angiotensin-converting enzyme 2 protects from severe acute lung failure
  publication-title: Nature
– volume: 7
  start-page: d1743
  year: 2002
  end-page: d1761
  ident: bib0066
  article-title: Molecular mechanisms of pulmonary fibrosis
  publication-title: Front Biosci
– volume: 77
  start-page: 301
  year: 2013
  end-page: 308
  ident: bib0103
  article-title: Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases
  publication-title: Circ J
– volume: 13
  start-page: 4872
  year: 2021
  end-page: 4884
  ident: bib0051
  article-title: Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis
  publication-title: J Thorac Dis
– volume: 386
  start-page: 509
  year: 2022
  end-page: 520
  ident: bib0077
  article-title: Molnupiravir for oral treatment of covid-19 in nonhospitalized patients
  publication-title: N Engl J Med
– volume: 11
  year: 2020
  ident: bib0009
  article-title: Clinical, serological, and histopathological similarities between severe COVID-19 and acute exacerbation of connective tissue disease-associated interstitial lung disease (CTD-ILD)
  publication-title: Front Immunol
– year: 2020
  ident: bib0022
  article-title: Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil
  publication-title: BMJ Evid Based Med
– volume: 128
  start-page: 36
  year: 2018
  end-page: 44
  ident: bib0065
  article-title: Insights from human genetic studies of lung and organ fibrosis
  publication-title: J Clin Invest
– volume: 141
  start-page: 7
  year: 2018
  end-page: 13
  ident: bib0113
  article-title: Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody
  publication-title: Respir Med
– volume: 46
  start-page: 239
  year: 2016
  end-page: 248
  ident: bib0102
  article-title: Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease
  publication-title: Shock
– volume: 14
  start-page: R167
  year: 2010
  ident: bib0053
  article-title: Host adaptive immunity deficiency in severe pandemic influenza
  publication-title: Crit Care
– volume: 9
  start-page: R157
  year: 2008
  ident: bib0131
  article-title: Boolean implication networks derived from large scale, whole genome microarray datasets
  publication-title: Genome Biol
– volume: 299
  start-page: E216
  year: 2021
  end-page: e8
  ident: bib0003
  article-title: Interstitial lung disease after COVID-19 infection: a catalog of uncertainties
  publication-title: Radiology
– volume: 130
  start-page: 5088
  year: 2020
  end-page: 5099
  ident: bib0088
  article-title: Contributions of alveolar epithelial cell quality control to pulmonary fibrosis
  publication-title: J Clin Invest
– volume: 26
  start-page: 842
  year: 2020
  end-page: 844
  ident: bib0059
  article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
  publication-title: Nat Med
– volume: 2011
  year: 2011
  ident: bib0012
  article-title: Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders
  publication-title: Pulm Med
– volume: 367
  start-page: 1814
  year: 2012
  end-page: 1820
  ident: bib0057
  article-title: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
  publication-title: N Engl J Med
– volume: 14
  year: 2019
  ident: bib0034
  article-title: Histochemical quantification of collagen content in articular cartilage
  publication-title: PLoS One
– volume: 7
  start-page: eabh2434
  year: 2021
  ident: bib0083
  article-title: Platelets amplify endotheliopathy in COVID-19
  publication-title: Sci Adv
– volume: 383
  start-page: 120
  year: 2020
  end-page: 128
  ident: bib0013
  article-title: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19
  publication-title: N Engl J Med
– volume: 21
  start-page: 2269
  year: 2020
  ident: bib0064
  article-title: Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis
  publication-title: Int J Mol Sci
– volume: 47
  start-page: 212
  year: 2016
  end-page: 222
  ident: bib0062
  article-title: Interleukin-15 is associated with disease severity in viral bronchiolitis
  publication-title: Eur Respir J
– volume: 22
  start-page: 1285
  year: 2016
  end-page: 1293
  ident: bib0122
  article-title: Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice
  publication-title: Nat Med
– volume: 162
  start-page: 156
  year: 2013
  end-page: 173
  ident: bib0124
  article-title: Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema
  publication-title: Transl Res
– volume: 123
  start-page: 3025
  year: 2013
  end-page: 3036
  ident: bib0091
  article-title: Type 2 alveolar cells are stem cells in adult lung
  publication-title: J Clin Invest
– volume: 12
  start-page: 814
  year: 2021
  ident: bib0080
  article-title: Efficacy and tolerability of bevacizumab in patients with severe Covid-19
  publication-title: Nat Commun
– volume: 92
  start-page: e01965
  year: 2018
  end-page: 17
  ident: bib0076
  article-title: β-d-N (4)-hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome
  publication-title: J Virol
– volume: 203
  start-page: 245
  year: 2021
  end-page: 249
  ident: bib0107
  article-title: Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease
  publication-title: Am J Respir Crit Care Med
– volume: 14
  year: 2019
  ident: bib0042
  article-title: A robust data-driven genomic signature for idiopathic pulmonary fibrosis with applications for translational model selection
  publication-title: PLoS One
– volume: 362
  start-page: 1353
  year: 2003
  end-page: 1358
  ident: bib0055
  article-title: Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
  publication-title: Lancet
– volume: 27
  start-page: 366
  issue: 3
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0067
  article-title: Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2020.06.020
– volume: 70
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0095
  article-title: Short telomeres and severe COVID-19: the connection conundrum
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2021.103513
– volume: 203
  start-page: 1609
  issue: 6
  year: 2019
  ident: 10.1016/j.ebiom.2022.104185_bib0023
  article-title: Influenza vaccination primes human myeloid cell cytokine secretion and NK cell function
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1801648
– volume: 12
  start-page: 3309
  issue: 1
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0030
  article-title: Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-23328-0
– volume: 436
  start-page: 112
  issue: 7047
  year: 2005
  ident: 10.1016/j.ebiom.2022.104185_bib0036
  article-title: Angiotensin-converting enzyme 2 protects from severe acute lung failure
  publication-title: Nature
  doi: 10.1038/nature03712
– volume: 12
  start-page: 814
  issue: 1
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0080
  article-title: Efficacy and tolerability of bevacizumab in patients with severe Covid-19
  publication-title: Nat Commun
  doi: 10.1038/s41467-021-21085-8
– volume: 378
  start-page: 1811
  issue: 19
  year: 2018
  ident: 10.1016/j.ebiom.2022.104185_bib0043
  article-title: Idiopathic pulmonary fibrosis
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra1705751
– volume: 17
  start-page: 779
  issue: 5
  year: 2011
  ident: 10.1016/j.ebiom.2022.104185_bib0033
  article-title: Quantification of collagen organization and extracellular matrix factors within the healing ligament
  publication-title: Microsc Microanal
  doi: 10.1017/S1431927611011925
– volume: 386
  start-page: 509
  issue: 6
  year: 2022
  ident: 10.1016/j.ebiom.2022.104185_bib0077
  article-title: Molnupiravir for oral treatment of covid-19 in nonhospitalized patients
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2116044
– volume: 9
  start-page: R157
  issue: 10
  year: 2008
  ident: 10.1016/j.ebiom.2022.104185_bib0131
  article-title: Boolean implication networks derived from large scale, whole genome microarray datasets
  publication-title: Genome Biol
  doi: 10.1186/gb-2008-9-10-r157
– volume: 5
  start-page: 857
  issue: 11
  year: 2017
  ident: 10.1016/j.ebiom.2022.104185_bib0027
  article-title: Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(17)30349-1
– volume: 47
  start-page: 212
  issue: 1
  year: 2016
  ident: 10.1016/j.ebiom.2022.104185_bib0062
  article-title: Interleukin-15 is associated with disease severity in viral bronchiolitis
  publication-title: Eur Respir J
  doi: 10.1183/13993003.00642-2015
– volume: 10
  start-page: 3150
  year: 2019
  ident: 10.1016/j.ebiom.2022.104185_bib0087
  article-title: Crucial involvement of IL-6 in thrombus resolution in mice via macrophage recruitment and the induction of proteolytic enzymes
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.03150
– volume: 202
  start-page: 1710
  issue: 12
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0104
  article-title: Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control Study
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.202006-2441LE
– volume: 62
  start-page: 319
  issue: 3
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0126
  article-title: PAI-1 regulation of TGF-β1-induced alveolar type II cell senescence, SASP secretion, and SASP-mediated activation of alveolar macrophages
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2019-0071OC
– volume: 128
  start-page: 36
  issue: 1
  year: 2018
  ident: 10.1016/j.ebiom.2022.104185_bib0065
  article-title: Insights from human genetic studies of lung and organ fibrosis
  publication-title: J Clin Invest
  doi: 10.1172/JCI93556
– volume: 54
  start-page: 259
  issue: 2
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0061
  article-title: Distinct developmental pathways from blood monocytes generate human lung macrophage diversity
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.12.003
– volume: 68
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0018
  article-title: AI-guided discovery of the invariant host response to viral pandemics
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2021.103390
– volume: 10
  start-page: 611
  issue: 3
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0016
  article-title: Emergency lung transplantation after COVID-19: immunopathological insights on two affected patients
  publication-title: Cells
  doi: 10.3390/cells10030611
– volume: 35
  start-page: 3705
  issue: 11
  year: 2007
  ident: 10.1016/j.ebiom.2022.104185_bib0019
  article-title: Extracting binary signals from microarray time-course data
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkm284
– volume: 9
  start-page: 1178
  issue: 4
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0050
  article-title: Severe fatigue is highly prevalent in patients with IPF or sarcoidosis
  publication-title: J Clin Med
  doi: 10.3390/jcm9041178
– volume: 212
  start-page: 681
  issue: 5
  year: 2015
  ident: 10.1016/j.ebiom.2022.104185_bib0060
  article-title: TREM-2 promotes macrophage survival and lung disease after respiratory viral infection
  publication-title: J Exp Med
  doi: 10.1084/jem.20141732
– volume: 112
  start-page: 5099
  issue: 16
  year: 2015
  ident: 10.1016/j.ebiom.2022.104185_bib0115
  article-title: Telomere dysfunction causes alveolar stem cell failure
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1504780112
– volume: 13
  start-page: 224
  issue: 4
  year: 2014
  ident: 10.1016/j.ebiom.2022.104185_bib0099
  article-title: ACE and ACE2 in inflammation: a tale of two enzymes
  publication-title: Inflamm Allergy Drug Targets
  doi: 10.2174/1871528113666140713164506
– volume: 383
  start-page: 120
  issue: 2
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0013
  article-title: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa2015432
– volume: 8
  issue: 1
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0049
  article-title: Fatigue in idiopathic pulmonary fibrosis measured by the fatigue assessment scale during antifibrotic treatment
  publication-title: Eur Clin Respir J
  doi: 10.1080/20018525.2020.1853658
– volume: 22
  start-page: 6151
  issue: 11
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0120
  article-title: Evidence for biological age acceleration and telomere shortening in COVID-19 survivors
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22116151
– volume: 10
  start-page: 362
  issue: 4
  year: 2013
  ident: 10.1016/j.ebiom.2022.104185_bib0038
  article-title: Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes
  publication-title: Ann Am Thorac Soc
  doi: 10.1513/AnnalsATS.201303-069FR
– volume: 13
  start-page: 1
  issue: 1
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0094
  article-title: Shorter telomere lengths in patients with severe COVID-19 disease
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.202463
– volume: 11
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0009
  article-title: Clinical, serological, and histopathological similarities between severe COVID-19 and acute exacerbation of connective tissue disease-associated interstitial lung disease (CTD-ILD)
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.587517
– volume: 3
  start-page: 24
  issue: 1
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0109
  article-title: Usefulness of pirfenidone in covid lung: a case series
  publication-title: Eur J Med Health Sci
  doi: 10.24018/ejmed.2021.3.1.670
– volume: 13
  start-page: 742
  issue: 6
  year: 2007
  ident: 10.1016/j.ebiom.2022.104185_bib0134
  article-title: Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment
  publication-title: Nat Med
  doi: 10.1038/nm1578
– ident: 10.1016/j.ebiom.2022.104185_bib0082
– volume: 22
  start-page: 484
  issue: 5
  year: 2016
  ident: 10.1016/j.ebiom.2022.104185_bib0037
  article-title: From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis
  publication-title: Curr Opin Pulm Med
  doi: 10.1097/MCP.0000000000000301
– volume: 13
  start-page: 4872
  issue: 8
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0051
  article-title: Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis
  publication-title: J Thorac Dis
  doi: 10.21037/jtd-21-462
– volume: 360
  start-page: 2666
  issue: 25
  year: 2009
  ident: 10.1016/j.ebiom.2022.104185_bib0054
  article-title: H1N1 influenza A disease–information for health professionals
  publication-title: N Engl J Med
  doi: 10.1056/NEJMe0903992
– volume: 203
  start-page: 245
  issue: 2
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0107
  article-title: Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.202007-2638LE
– volume: 299
  start-page: E216
  issue: 1
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0003
  article-title: Interstitial lung disease after COVID-19 infection: a catalog of uncertainties
  publication-title: Radiology
  doi: 10.1148/radiol.2021204482
– volume: 201
  start-page: 198
  issue: 2
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0121
  article-title: Grp78 loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201902-0451OC
– volume: 13
  start-page: e12501
  issue: 1
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0005
  article-title: Restrictive lung disease in patients with subclinical coronavirus infection: are we bracing ourselves for devastating sequelae?
  publication-title: Cureus
– volume: 362
  start-page: 1353
  issue: 9393
  year: 2003
  ident: 10.1016/j.ebiom.2022.104185_bib0055
  article-title: Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)14630-2
– volume: 12
  start-page: eabb5883
  issue: 541
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0075
  article-title: An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.abb5883
– volume: 4
  start-page: 7027
  year: 2014
  ident: 10.1016/j.ebiom.2022.104185_bib0078
  article-title: Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury
  publication-title: Sci Rep
  doi: 10.1038/srep07027
– volume: 9
  start-page: e96801
  issue: 5
  year: 2014
  ident: 10.1016/j.ebiom.2022.104185_bib0032
  article-title: IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0096801
– volume: 18
  start-page: 799
  issue: 5
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0002
  article-title: Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment
  publication-title: Ann Am Thorac Soc
  doi: 10.1513/AnnalsATS.202008-1002OC
– volume: 183
  start-page: 173
  issue: 1
  year: 2013
  ident: 10.1016/j.ebiom.2022.104185_bib0086
  article-title: Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2013.03.014
– volume: 7
  start-page: eabh2434
  issue: 37
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0083
  article-title: Platelets amplify endotheliopathy in COVID-19
  publication-title: Sci Adv
  doi: 10.1126/sciadv.abh2434
– volume: 49
  start-page: D605
  issue: D1
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0021
  article-title: The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkaa1074
– volume: 6
  start-page: 11
  issue: 1
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0072
  article-title: Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
  publication-title: Nat Microbiol
  doi: 10.1038/s41564-020-00835-2
– volume: 6
  start-page: 051
  issue: 1
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0110
  article-title: Post-inflammatory pulmonary fibrosis in a discharged COVID-19 patient: Effectively treated with Pirfenidone
  publication-title: Archives of Pulmonology and Respiratory Care
– volume: 202
  start-page: 1656
  issue: 12
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0105
  article-title: Outcome of Hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.202007-2794OC
– volume: 4
  start-page: 70
  year: 2011
  ident: 10.1016/j.ebiom.2022.104185_bib0039
  article-title: Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle
  publication-title: BMC Med Genomics
  doi: 10.1186/1755-8794-4-70
– volume: 32
  start-page: 513
  year: 2014
  ident: 10.1016/j.ebiom.2022.104185_bib0117
  article-title: Interferon-stimulated genes: a complex web of host defenses
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev-immunol-032713-120231
– volume: 206
  start-page: 167
  issue: 2
  year: 2012
  ident: 10.1016/j.ebiom.2022.104185_bib0116
  article-title: Critical role of natural killer cells in lung immunopathology during influenza infection in mice
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jis340
– volume: 201
  start-page: 198
  issue: 2
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0089
  article-title: Loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201902-0451OC
– year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0022
  article-title: Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil
  publication-title: BMJ Evid Based Med
– volume: 40
  start-page: 1823
  issue: 9
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0008
  article-title: Residual lung injury in patients recovering from COVID-19 critical illness: a prospective longitudinal point-of-care lung ultrasound study
  publication-title: J Ultrasound Med
  doi: 10.1002/jum.15563
– volume: 72
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0071
  article-title: The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2021.103595
– volume: 130
  start-page: 5088
  issue: 10
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0088
  article-title: Contributions of alveolar epithelial cell quality control to pulmonary fibrosis
  publication-title: J Clin Invest
  doi: 10.1172/JCI139519
– volume: 107
  start-page: 5732
  issue: 13
  year: 2010
  ident: 10.1016/j.ebiom.2022.104185_bib0132
  article-title: MiDReG: a method of mining developmentally regulated genes using Boolean implications
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0913635107
– volume: 6
  issue: 65
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0014
  article-title: Immune signatures underlying post-acute COVID-19 lung sequelae
  publication-title: Sci Immunol
  doi: 10.1126/sciimmunol.abk1741
– volume: 20
  start-page: 2557
  issue: 3
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0079
  article-title: Pulmonary fibrosis in the aftermath of the COVID-19 era (Review)
  publication-title: Exp Ther Med
– volume: 22
  start-page: 1285
  issue: 11
  year: 2016
  ident: 10.1016/j.ebiom.2022.104185_bib0122
  article-title: Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice
  publication-title: Nat Med
  doi: 10.1038/nm.4192
– volume: 66
  start-page: 107
  issue: 1
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0129
  article-title: Evidence that SARS-CoV-2 induces lung-cell senescence: potential impact on COVID-19 lung disease
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2021-0205LE
– volume: 9
  start-page: 487
  issue: 5
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0017
  article-title: Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(21)00077-1
– volume: 22
  start-page: 934
  issue: 8
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0069
  article-title: Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-020-0542-8
– volume: 96
  start-page: 2578
  issue: 6
  year: 1995
  ident: 10.1016/j.ebiom.2022.104185_bib0026
  article-title: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro
  publication-title: J Clin Invest
  doi: 10.1172/JCI118321
– volume: 8
  start-page: 807
  issue: 8
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0010
  article-title: Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30225-3
– volume: 123
  start-page: 3025
  issue: 7
  year: 2013
  ident: 10.1016/j.ebiom.2022.104185_bib0091
  article-title: Type 2 alveolar cells are stem cells in adult lung
  publication-title: J Clin Invest
  doi: 10.1172/JCI68782
– volume: 22
  start-page: 5131
  issue: 10
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0085
  article-title: Pathophysiological association of endothelial dysfunction with fatal outcome in COVID-19
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22105131
– volume: 13
  start-page: 2687
  issue: 1
  year: 2022
  ident: 10.1016/j.ebiom.2022.104185_bib0035
  article-title: An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease
  publication-title: Nat Commun
  doi: 10.1038/s41467-022-30357-w
– volume: 9
  start-page: R85
  issue: 5
  year: 2007
  ident: 10.1016/j.ebiom.2022.104185_bib0114
  article-title: Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar2284
– volume: 23
  start-page: e01041
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0007
  article-title: Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection
  publication-title: IDCases
  doi: 10.1016/j.idcr.2020.e01041
– volume: 77
  start-page: 301
  issue: 2
  year: 2013
  ident: 10.1016/j.ebiom.2022.104185_bib0103
  article-title: Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases
  publication-title: Circ J
  doi: 10.1253/circj.CJ-12-1544
– volume: 14
  start-page: R167
  issue: 5
  year: 2010
  ident: 10.1016/j.ebiom.2022.104185_bib0053
  article-title: Host adaptive immunity deficiency in severe pandemic influenza
  publication-title: Crit Care
  doi: 10.1186/cc9259
– volume: 7
  start-page: d1743
  year: 2002
  ident: 10.1016/j.ebiom.2022.104185_bib0066
  article-title: Molecular mechanisms of pulmonary fibrosis
  publication-title: Front Biosci
  doi: 10.2741/pardo
– volume: 218
  start-page: 16
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0073
  article-title: Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2019.12.002
– volume: 6
  start-page: eaba1983
  issue: 28
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0045
  article-title: Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
  publication-title: Sci Adv
  doi: 10.1126/sciadv.aba1983
– volume: 22
  start-page: 6214
  issue: 12
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0098
  article-title: Cellular senescence: pathogenic mechanisms in lung fibrosis
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22126214
– volume: 11
  issue: 6
  year: 2015
  ident: 10.1016/j.ebiom.2022.104185_bib0058
  article-title: Host transcriptional response to influenza and other acute respiratory viral infections–a prospective cohort study
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1004869
– volume: 14
  issue: 4
  year: 2019
  ident: 10.1016/j.ebiom.2022.104185_bib0042
  article-title: A robust data-driven genomic signature for idiopathic pulmonary fibrosis with applications for translational model selection
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0215565
– volume: 5
  start-page: 4451
  year: 2014
  ident: 10.1016/j.ebiom.2022.104185_bib0029
  article-title: GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis
  publication-title: Nat Commun
  doi: 10.1038/ncomms5451
– volume: 585
  start-page: 339
  issue: 7825
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0048
  article-title: The lasting misery of coronavirus long-haulers
  publication-title: Nature
  doi: 10.1038/d41586-020-02598-6
– volume: 180
  start-page: 1395
  issue: 4
  year: 1994
  ident: 10.1016/j.ebiom.2022.104185_bib0025
  article-title: Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor
  publication-title: J Exp Med
  doi: 10.1084/jem.180.4.1395
– volume: 202
  start-page: 1614
  issue: 12
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0106
  article-title: COVID-19 and interstitial lung disease: keep them separate
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.202010-3918ED
– volume: 19
  issue: 6
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0111
  article-title: The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2020.102537
– volume: 162
  start-page: 156
  issue: 3
  year: 2013
  ident: 10.1016/j.ebiom.2022.104185_bib0124
  article-title: Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema
  publication-title: Transl Res
  doi: 10.1016/j.trsl.2013.06.004
– volume: 12
  issue: 574
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0015
  article-title: Lung transplantation for patients with severe COVID-19
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.abe4282
– volume: 203
  start-page: 3000
  issue: 11
  year: 2019
  ident: 10.1016/j.ebiom.2022.104185_bib0101
  article-title: A dynamic variation of pulmonary ACE2 is required to modulate neutrophilic inflammation in response to
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1900579
– volume: 92
  start-page: e01965
  issue: 3
  year: 2018
  ident: 10.1016/j.ebiom.2022.104185_bib0076
  article-title: β-d-N (4)-hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome
  publication-title: J Virol
  doi: 10.1128/JVI.01965-17
– volume: 369
  start-page: 956
  issue: 6506
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0031
  article-title: Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
  publication-title: Science
  doi: 10.1126/science.abc7520
– volume: 14
  start-page: 14
  issue: 12
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0108
  article-title: Clinical improvement with pirfenidone in two patients of COVID 19
  publication-title: J Clin Diagnostic Res
– year: 2022
  ident: 10.1016/j.ebiom.2022.104185_bib0127
  article-title: Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis
  publication-title: Eur Respir J
  doi: 10.1183/13993003.02951-2021
– volume: 9
  start-page: 747
  issue: 7
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0047
  article-title: 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(21)00174-0
– volume: 13
  start-page: 197
  issue: 1
  year: 2014
  ident: 10.1016/j.ebiom.2022.104185_bib0093
  article-title: Endoplasmic reticulum stress activates telomerase
  publication-title: Aging Cell
  doi: 10.1111/acel.12161
– volume: 353
  start-page: 1374
  issue: 13
  year: 2005
  ident: 10.1016/j.ebiom.2022.104185_bib0056
  article-title: Avian influenza A (H5N1) infection in humans
  publication-title: N Engl J Med
  doi: 10.1056/NEJMra052211
– volume: 18
  start-page: 773
  issue: 5
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0004
  article-title: Lungs after COVID-19: evolving knowledge of post-COVID-19 interstitial lung disease
  publication-title: Ann Am Thorac Soc
  doi: 10.1513/AnnalsATS.202102-223ED
– volume: 2011
  year: 2011
  ident: 10.1016/j.ebiom.2022.104185_bib0012
  article-title: Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders
  publication-title: Pulm Med
  doi: 10.1155/2011/531302
– volume: 52
  start-page: 130
  issue: 1
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0125
  article-title: TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency
  publication-title: Exp Mol Med
  doi: 10.1038/s12276-019-0371-7
– volume: 141
  start-page: 7
  year: 2018
  ident: 10.1016/j.ebiom.2022.104185_bib0113
  article-title: Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody
  publication-title: Respir Med
  doi: 10.1016/j.rmed.2018.06.012
– volume: 76
  start-page: 1242
  issue: 12
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0119
  article-title: Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length
  publication-title: Thorax
  doi: 10.1136/thoraxjnl-2021-217031
– volume: 23
  start-page: 2376
  issue: 20
  year: 2009
  ident: 10.1016/j.ebiom.2022.104185_bib0100
  article-title: Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development
  publication-title: Genes Dev
  doi: 10.1101/gad.1836009
– volume: 12
  start-page: 19911
  issue: 20
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0118
  article-title: Short telomeres increase the risk of severe COVID-19
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.104097
– volume: 21
  start-page: 319
  issue: 5
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0084
  article-title: Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
  publication-title: Nat Rev Immunol
  doi: 10.1038/s41577-021-00536-9
– volume: 132
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0097
  article-title: Cell senescence and fibrotic lung diseases
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2020.110836
– volume: 10
  start-page: e224
  issue: 7
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0046
  article-title: Persistent viral activity, cytokine storm, and lung fibrosis in a case of severe COVID-19
  publication-title: Clin Transl Med
  doi: 10.1002/ctm2.224
– volume: 17
  start-page: 2312
  issue: 9
  year: 2016
  ident: 10.1016/j.ebiom.2022.104185_bib0092
  article-title: Emergence of a wave of wnt signaling that regulates lung alveologenesis by controlling epithelial self-renewal and differentiation
  publication-title: Cell Rep
  doi: 10.1016/j.celrep.2016.11.001
– volume: 22
  start-page: 1025
  issue: 9
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0096
  article-title: A transitional stem cell state in the lung
  publication-title: Nat Cell Biol
  doi: 10.1038/s41556-020-0561-5
– volume: 46
  start-page: D649
  issue: D1
  year: 2018
  ident: 10.1016/j.ebiom.2022.104185_bib0020
  article-title: The reactome pathway knowledgebase
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkx1132
– volume: 10
  start-page: e66417
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0028
  article-title: Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19
  publication-title: Elife
  doi: 10.7554/eLife.66417
– volume: 14
  issue: 11
  year: 2019
  ident: 10.1016/j.ebiom.2022.104185_bib0034
  article-title: Histochemical quantification of collagen content in articular cartilage
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0224839
– volume: 199
  start-page: 1517
  issue: 12
  year: 2019
  ident: 10.1016/j.ebiom.2022.104185_bib0044
  article-title: Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201712-2410OC
– volume: 21
  start-page: 2269
  issue: 7
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0064
  article-title: Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21072269
– volume: 203
  start-page: 707
  issue: 6
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0070
  article-title: Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.202004-1274OC
– volume: 52
  start-page: 217
  issue: 2
  year: 2015
  ident: 10.1016/j.ebiom.2022.104185_bib0040
  article-title: A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/rcmb.2013-0310OC
– volume: 108
  start-page: E1475
  issue: 52
  year: 2011
  ident: 10.1016/j.ebiom.2022.104185_bib0090
  article-title: Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1117988108
– volume: 49
  issue: 10
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0011
  article-title: Functional outcomes and their association with physical performance in mechanically ventilated coronavirus disease 2019 survivors at 3 months following hospital discharge: a cohort study
  publication-title: Crit Care Med
  doi: 10.1097/CCM.0000000000005089
– volume: 11
  start-page: eaax5866
  issue: 515
  year: 2019
  ident: 10.1016/j.ebiom.2022.104185_bib0074
  article-title: Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.aax5866
– volume: 108
  start-page: 970
  issue: 6
  year: 2001
  ident: 10.1016/j.ebiom.2022.104185_bib0112
  article-title: Expression of IL-15 in inflammatory pulmonary diseases
  publication-title: J Allergy Clin Immunol
  doi: 10.1067/mai.2001.119556
– volume: 367
  start-page: 1814
  issue: 19
  year: 2012
  ident: 10.1016/j.ebiom.2022.104185_bib0057
  article-title: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1211721
– volume: 599
  start-page: 283
  issue: 7884
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0128
  article-title: Virus-induced senescence is a driver and therapeutic target in COVID-19
  publication-title: Nature
  doi: 10.1038/s41586-021-03995-1
– volume: 11
  start-page: 3559
  issue: 1
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0068
  article-title: Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis
  publication-title: Nat Commun
  doi: 10.1038/s41467-020-17358-3
– volume: 46
  start-page: 239
  issue: 3
  year: 2016
  ident: 10.1016/j.ebiom.2022.104185_bib0102
  article-title: Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease
  publication-title: Shock
  doi: 10.1097/SHK.0000000000000633
– volume: 51
  start-page: 56
  issue: 1
  year: 2010
  ident: 10.1016/j.ebiom.2022.104185_bib0052
  article-title: The new influenza A H1N1 virus: balancing on the interface of humans and animals
  publication-title: Can Vet J
– volume: 7
  start-page: 1554
  issue: 1
  year: 2017
  ident: 10.1016/j.ebiom.2022.104185_bib0041
  article-title: Detecting the molecular system signatures of idiopathic pulmonary fibrosis through integrated genomic analysis
  publication-title: Sci Rep
  doi: 10.1038/s41598-017-01765-6
– volume: 26
  start-page: 842
  issue: 6
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0059
  article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
  publication-title: Nat Med
  doi: 10.1038/s41591-020-0901-9
– volume: 8
  start-page: 750
  issue: 8
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0001
  article-title: Pulmonary fibrosis secondary to COVID-19: a call to arms?
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(20)30222-8
– volume: 10
  issue: 2
  year: 2015
  ident: 10.1016/j.ebiom.2022.104185_bib0024
  article-title: A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0118528
– volume: 30
  start-page: 1770
  issue: 14
  year: 2019
  ident: 10.1016/j.ebiom.2022.104185_bib0133
  article-title: Unbiased Boolean analysis of public gene expression data for cell cycle gene identification
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.E19-01-0013
– volume: 10
  start-page: 531
  issue: 7
  year: 2019
  ident: 10.1016/j.ebiom.2022.104185_bib0063
  article-title: SCINA: a semi-supervised subtyping algorithm of single cells and bulk samples
  publication-title: Genes (Basel)
  doi: 10.3390/genes10070531
– volume: 40
  issue: 5
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0081
  article-title: An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells
  publication-title: EMBO J
  doi: 10.15252/embj.2020105912
– volume: 56
  start-page: 1
  year: 2020
  ident: 10.1016/j.ebiom.2022.104185_bib0006
  article-title: Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: a narrative review
  publication-title: Can J Respir Ther
– volume: 1
  start-page: e90558
  issue: 20
  year: 2016
  ident: 10.1016/j.ebiom.2022.104185_bib0123
  article-title: Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.90558
– volume: 13
  start-page: eabj7790
  issue: 620
  year: 2021
  ident: 10.1016/j.ebiom.2022.104185_bib0130
  article-title: Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.abj7790
– reference: 34873597 - bioRxiv. 2022 Jul 18:2021.11.28.470269. doi: 10.1101/2021.11.28.470269
SSID ssj0001542358
Score 2.3647463
Snippet In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into...
SummaryBackgroundIn the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post- COVID-19 lung disease (PCLD), for which we currently...
Background: In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 104185
SubjectTerms Adult
Advanced Basic Science
Alveolar type II pneumocytes
Animals
Artificial intelligence/machine learning
COVID-19
Cytokine Release Syndrome
Damage-associated transient progenitor (DATP)
ER-stress
Humans
Idiopathic Pulmonary Fibrosis - genetics
Idiopathic Pulmonary Fibrosis - metabolism
Immune response
Interleukin 15 (IL15)
Internal Medicine
Lung - pathology
Mice
SARS-CoV-2
Senescence
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDfhJSNxJMJx_IiPpVC1SMCBFvWE5Ti2utUqW212D_vvmbGT1S6g9sI1ifOYGXu-iWe-IeQd64JDZiqITbQsRdSsbIWpS8dirRpwsj6Vj339pk7OxZcLebHT6gtzwjI9cBbch05GY7yEuWCcQH47F8ClN8xrJ2PrE88nM2wnmMr1wQJrQFNnOcnL2igxUQ6l5K6Axe0QHXKOm5wVdlLecUuJvX_PO_2NPv9MotzxSscPyP0RTtLD_BkPyZ3QPyJ3c4PJzWPy6-j7z9NPZWXoHCY1HXdj6HCJVUe0W2JSBj0849RvVovUnNjTGBLX50DxFy097WbTiev1HGzWLTc0Qoy9GGbDE3J-_Pns6KQcOyqUXtV8VTZt55lxAOoE1x6wi6u446EJQUplwJ1pF8GnayEAZbSx7prAXNOaymkQPqC1p-SgX_ThOcGXkY5H18YqiuAbVykDsmicalUttC8InwRq_Ug3jl0v5nbKK7uySQsWtWCzFgryfjvoOrNt3Hz5R9TU9lKkyk4HwIDsaED2NgMqiJj0bKdqVFg_4Uazm5-t_zUsDOMaMNjKDtwy-wMtEA2QYx6gUk1B1HbkCHMyfLn9kW8nM7SwCODOjuvDYj1YrgwSRwKWL8izbJZbocA00BgYwwvvGeye1PbP9LPLRDQO0BkApH7xP8T8ktzDT8m5k6_IwWq5Dq8Bz63aN2nq_gYcFEVJ
  priority: 102
  providerName: Directory of Open Access Journals
Title COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2352396422003668
https://www.clinicalkey.es/playcontent/1-s2.0-S2352396422003668
https://dx.doi.org/10.1016/j.ebiom.2022.104185
https://www.ncbi.nlm.nih.gov/pubmed/35870428
https://www.proquest.com/docview/2693779977
https://pubmed.ncbi.nlm.nih.gov/PMC9297827
https://doaj.org/article/d5f99c58879a40249ae39280c7a5fbc3
Volume 82
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEaiXijdboDISR4ISx7HjA0KlULVIhQNd1BOW49jtolVSkl2J_ffMJPFCYFUkrokncWbGnm_ieRDyIi6dwcpU4JvILOJexlHBVRqZ2KciByNru_Sx04_ieMo_nGfnWyR0RR0Y2G507bCf1LSZv_rxffUGFvzrX7FaDnPVwdljDM8swQTdIDfBNAn0xk4HvN-nDXNMDQ3VhzbT7pDbMEaiMzEyVl1N_5HN-huT_hla-ZutOrpDdgeQSQ96rbhLtlx1j9zq206u7pOvh5--nLyLEkXnsNTpcEZD20vMRaJlg6Ea9OCMUbta1F3LYku96yqAthR_3NKTchZuXC3noMmmWVEPnnfdztoHZHr0_uzwOBr6LERWpGwR5UVpY2UA6nEmLSAakzDDXO5clgkFRk4aD5Zecg7Yo_BpmbvY5IVKjDQcMdxDsl3VlXtMcDKZYd4UPvHc2dwkQgEvciMKkXJpJ4QFhmo7FCHHXhhzHaLNvulOIBoFonuBTMjLNdFVX4Pj-uFvUVLroVhAu7tQNxd6WI-6zLxSNoMtVsE3gA9qHCDFPLbSZL6w6YTwIGcdclRhV4UHza5_t9xE5tqg2DrRLdOx_gx6yFIF3h9GBwqRT4hYUw7gpwc1_37l86CGGrYGPO8xlauXrWZCYTlJQPgT8qhXyzVTgobDhEcKO-La-E41u-zKjwOgBlgp9_6b8gnZwfn3YZRPyfaiWbpnAO0WxX73S2S_W7Q_AfolTbw
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COVID-19+lung+disease+shares+driver+AT2+cytopathic+features+with+Idiopathic+pulmonary+fibrosis&rft.jtitle=EBioMedicine&rft.au=Sinha%2C+Saptarshi&rft.au=Castillo%2C+Vanessa&rft.au=Espinoza%2C+Celia+R.&rft.au=Tindle%2C+Courtney&rft.date=2022-08-01&rft.pub=Elsevier&rft.eissn=2352-3964&rft.volume=82&rft_id=info:doi/10.1016%2Fj.ebiom.2022.104185&rft_id=info%3Apmid%2F35870428&rft.externalDocID=PMC9297827
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F23523964%2Fcov200h.gif